UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis

Pediatric blood & cancer, 2023-10, Vol.70 (10), p.e30601-n/a

2023

Volltextzugriff (PDF)

CP-04. UNVEILING THE MYSTERIES OF PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA - INSIGHTS FROM DIAGNOSIS TO ADVANCED THERAPEUTICS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement

Frontiers in oncology, 2022-07, Vol.12, p.932337-932337

2022

Volltextzugriff (PDF)

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas

Acta neuropathologica communications, 2021-12, Vol.9 (1), p.192-192, Article 192

2021

Volltextzugriff (PDF)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia

Signal transduction and targeted therapy, 2019-11, Vol.4 (1), p.44-44, Article 44

2019

Volltextzugriff (PDF)

HGG-35. SIGNIFICANT RESPONSE TO LAROTRECTINIB AS FIRST LINE THERAPY IN INFANT WITH INFANT-TYPE HEMISPHERIC GLIOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

GCT-06. THE OUTCOMES OF PATIENTS WITH DISSEMINATED GERMINOMA TREATED ON ACNS0232: A REPORT FROM THE CHILDREN’S ONCOLOGY REPORT

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

RADT-36. MANAGEMENT OF PATIENTS WITH METASTATIC CENTRAL NERVOUS SYSTEM (CNS) GERMINOMA; A LITERATURE REVIEW

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii57-vii57

2022

Volltextzugriff (PDF)

Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies

Pediatric blood & cancer, 2024-06, Vol.71 (6), p.e30979-n/a

2024

Volltextzugriff (PDF)

NURS-02. THE DEVELOPMENT AND IMPLEMENTATION OF SKINCARE TREATMENT PLANS AND PRODUCT KITS FOR PEDIATRIC PATIENTS RECEIVING TARGETED THERAPIES THAT CAUSE SKIN TOXICITY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

NURS-07. A NEEDS ASSESSMENT OF THE BRAIN TUMOR EDUCATION AND THERAPY (BEAT) GROUP AT WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

ETMR-32. SUPRATENTORIAL NEUROEPITHELIAL TUMOR WITH PLAGL1 FUSION: A CASE REPORT

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

LGG-24. PEDIATRIC GANGLIOGLIOMA WITH GERMLINE BRCA2 MUTATION

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

NFS-19. ATYPICAL PRESENTATION OF GLIOMAS IN ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1): A CASE SERIES

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

HGG-33. HIGH GRADE TRANSFORMATION OF CNS TUMOR WITH BCOR:CREBBP FUSION: A CASE REPORT

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

TRLS-05. A PILOT STUDY TO ASSESS THE SAFETY, FEASIBILITY, AND PRELIMINARY EFFICACY OF A NEOEPITOPE-BASED PERSONALIZED DNA VACCINE APPROACH IN PEDIATRIC PATIENTS WITH RECURRENT BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

NURS-01. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BY TARGETED THERAPIES IN THE PEDIATRIC POPULATION

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

LGG-35. ROBUST TUMOR RESPONSE TO CHEMOTHERAPY IN THALAMIC PILOCYTIC ASTROCYTOMA WITH LARGE CYSTIC COMPONENT: A CASE REPORT

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

GCT-25. THE IMPACT OF RESIDUAL DISEASE ON THE OUTCOMES OF CENTRAL NERVOUS SYSTEM GERMINOMAS – A MULTICENTER INSTITUTION EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

LGG-55. DIFFERENTIAL TOXICITY PROFILE OF INDIVIDUAL MEK INHIBITORS: A MULTI-INSTITUTION RETROSPECTIVE REVIEW

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

LMIC-06. WEB-BASED SURVEY RESULTS OF THE INTERNATIONAL PEDIATRIC NEURO-ONCOLOGY TUMOR BOARD AT WASHINGTON UNIVERSITY IN ST. LOUIS SCHOOL OF MEDICINE

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

RARE-27. Treatment and outcomes in atypical choroid plexus papilloma: a single institution experience

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i15-i15

2022

Volltextzugriff (PDF)

LGG-39. Ascites in a medullary and leptomeningeal ganglioglioma patient following cisplatin treatment necessitating cessation of therapy and conversion to VA shunt

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i97-i97

2022

Volltextzugriff (PDF)

GCT-14. The Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – A Single Institution Experience

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i57-i57

2022

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(56)
Berichte
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Oncology
(6)
Pediatrics
(6)
Low Grade Glioma
(5)
Germ Cell Tumors
(4)
Hematology
(4)
Neurosciences & Neurology
(4)
Tumors
(4)
Case Report
(3)
Chromosomes
(3)
Craniopharyngioma And Rare Tumors
(3)
Final Category: Germ Cell Tumors
(3)
Final Category: Low Grade Glioma
(3)
Final Category: Nursing, Social Work, Patient Support
(3)
Humans
(3)
Medulloblastoma
(3)
Neurosciences
(3)
Cancer
(2)
Chemotherapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis

CP-04. UNVEILING THE MYSTERIES OF PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA - INSIGHTS FROM DIAGNOSIS TO ADVANCED THERAPEUTICS

Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas

Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia

HGG-35. SIGNIFICANT RESPONSE TO LAROTRECTINIB AS FIRST LINE THERAPY IN INFANT WITH INFANT-TYPE HEMISPHERIC GLIOMA

GCT-06. THE OUTCOMES OF PATIENTS WITH DISSEMINATED GERMINOMA TREATED ON ACNS0232: A REPORT FROM THE CHILDREN’S ONCOLOGY REPORT

RADT-36. MANAGEMENT OF PATIENTS WITH METASTATIC CENTRAL NERVOUS SYSTEM (CNS) GERMINOMA; A LITERATURE REVIEW

Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies

NURS-02. THE DEVELOPMENT AND IMPLEMENTATION OF SKINCARE TREATMENT PLANS AND PRODUCT KITS FOR PEDIATRIC PATIENTS RECEIVING TARGETED THERAPIES THAT CAUSE SKIN TOXICITY

NURS-07. A NEEDS ASSESSMENT OF THE BRAIN TUMOR EDUCATION AND THERAPY (BEAT) GROUP AT WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS

ETMR-32. SUPRATENTORIAL NEUROEPITHELIAL TUMOR WITH PLAGL1 FUSION: A CASE REPORT

LGG-24. PEDIATRIC GANGLIOGLIOMA WITH GERMLINE BRCA2 MUTATION

NFS-19. ATYPICAL PRESENTATION OF GLIOMAS IN ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1): A CASE SERIES

HGG-33. HIGH GRADE TRANSFORMATION OF CNS TUMOR WITH BCOR:CREBBP FUSION: A CASE REPORT

TRLS-05. A PILOT STUDY TO ASSESS THE SAFETY, FEASIBILITY, AND PRELIMINARY EFFICACY OF A NEOEPITOPE-BASED PERSONALIZED DNA VACCINE APPROACH IN PEDIATRIC PATIENTS WITH RECURRENT BRAIN TUMORS

NURS-01. NOVEL TREATMENTS FOR ACNEIFORM ERUPTIONS CAUSED BY TARGETED THERAPIES IN THE PEDIATRIC POPULATION

LGG-35. ROBUST TUMOR RESPONSE TO CHEMOTHERAPY IN THALAMIC PILOCYTIC ASTROCYTOMA WITH LARGE CYSTIC COMPONENT: A CASE REPORT

GCT-25. THE IMPACT OF RESIDUAL DISEASE ON THE OUTCOMES OF CENTRAL NERVOUS SYSTEM GERMINOMAS – A MULTICENTER INSTITUTION EXPERIENCE

LGG-55. DIFFERENTIAL TOXICITY PROFILE OF INDIVIDUAL MEK INHIBITORS: A MULTI-INSTITUTION RETROSPECTIVE REVIEW

LMIC-06. WEB-BASED SURVEY RESULTS OF THE INTERNATIONAL PEDIATRIC NEURO-ONCOLOGY TUMOR BOARD AT WASHINGTON UNIVERSITY IN ST. LOUIS SCHOOL OF MEDICINE

RARE-27. Treatment and outcomes in atypical choroid plexus papilloma: a single institution experience

LGG-39. Ascites in a medullary and leptomeningeal ganglioglioma patient following cisplatin treatment necessitating cessation of therapy and conversion to VA shunt

GCT-14. The Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – A Single Institution Experience

Suchergebnisse filtern